A DOG TEST FOR MEASURING THE IMMUNIZING POTENCY OF ANTIRABIES VACCINES

Area of Science:

• Veterinary immunology
• Vaccinology
• Animal health

Background:

• Antirabies vaccines are crucial for canine disease prevention.
• Assessing vaccine efficacy in target animal species is essential.
• Previous studies indicated potential issues with canine vaccine potency.

Purpose of the Study:

• To quantitatively evaluate the immunizing potency of commercially available antirabies vaccines in dogs.
• To compare the efficacy of phenolized and chloroformized vaccine formulations.
• To explore alternative administration routes for improved vaccine effectiveness.

Main Methods:

• A quantitative assay was employed to test vaccine potency in dogs.
• Dogs were vaccinated with commercial canine vaccines from multiple manufacturers.
• Vaccinated dogs were challenged with a standardized dose of rabies virus.

Main Results:

• Phenolized vaccines from seven manufacturers failed to protect dogs against a minimal lethal virus dose.
• Chloroformized vaccines showed equivocal or suggestive protective results in dogs.
• Intraperitoneal administration of chloroformized vaccines conferred significant immunity but caused transient peritoneal irritation.

Conclusions:

• Many commercial antirabies vaccines lack sufficient immunizing potency in dogs.
• Chloroformized vaccines, when administered intraperitoneally, offer a degree of protection.
• Further research is needed to optimize canine rabies vaccine efficacy and delivery.